Table 1 Patients’ characteristics at baseline
|  | Characteristics of Study Population n = 572 |
|---|---|
Demographic | |
Gender | |
 male, n (%) | 303 (53.0%) |
 female, n (%) | 269 (47.0%) |
Age, years, median (IQR) | 55 (47–62) |
Comorbidities | |
 Presence of comorbidities, n (%) | 215 (37.6%) |
Number of comorbidities | |
 1, n (%) | 152 (26.6%) |
 2, n (%) | 44 (7.7%) |
 ≥ 3, n (%) | 19 (3.3%) |
Distance from acute phase | |
 Months from acute phase, median (IQR) | 4.8 (3.6–7.1) |
 3 months, n (%) | 235 (41.1%) |
 6 months, n (%) | 175 (30.6%) |
  > 6 months, n (%) | 118 (20.6%) |
 Previous hospitalization, n (%) | 309 (54.0%) |
 Non-invasive ventilation, n (%) | 104 (18.2%) |
 Intensive Care Unit, n (%) | 11 (1.9%) |
Treatment in the acute phase | |
 corticosteroids, n (%) | 323 (56.5%) |
 remdesivir, n (%) | 145 (25.4%) |
 immunotherapy, n (%) | 10 (1.8%) |
 heparin, n (%) | 258 (45.1%) |